Vanguard Group
SLS icon

Vanguard Group’s SELLAS Life Sciences SLS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$14.6M Buy
6,654,799
+3,815,481
+134% +$8.36M ﹤0.01% 2713
2025
Q1
$3.07M Buy
2,839,318
+546,461
+24% +$590K ﹤0.01% 3342
2024
Q4
$2.38M Hold
2,292,857
﹤0.01% 3508
2024
Q3
$2.87M Buy
2,292,857
+506,523
+28% +$633K ﹤0.01% 3448
2024
Q2
$2.13M Buy
1,786,334
+273,099
+18% +$325K ﹤0.01% 3538
2024
Q1
$1.53M Buy
1,513,235
+365,911
+32% +$370K ﹤0.01% 3676
2023
Q4
$1.22M Buy
1,147,324
+110,418
+11% +$117K ﹤0.01% 3767
2023
Q3
$1.7M Buy
1,036,906
+90,198
+10% +$148K ﹤0.01% 3644
2023
Q2
$1.49M Buy
946,708
+49,796
+6% +$78.2K ﹤0.01% 3766
2023
Q1
$1.28M Buy
896,912
+40,828
+5% +$58.4K ﹤0.01% 3839
2022
Q4
$2.02M Buy
856,084
+25,965
+3% +$61.3K ﹤0.01% 3648
2022
Q3
$1.68M Hold
830,119
﹤0.01% 3815
2022
Q2
$1.85M Buy
830,119
+173,200
+26% +$386K ﹤0.01% 3837
2022
Q1
$4.39M Buy
656,919
+2,357
+0.4% +$15.7K ﹤0.01% 3597
2021
Q4
$3.62M Buy
654,562
+3,279
+0.5% +$18.1K ﹤0.01% 3787
2021
Q3
$5.97M Buy
651,283
+32,749
+5% +$300K ﹤0.01% 3539
2021
Q2
$6.87M Buy
618,534
+148,681
+32% +$1.65M ﹤0.01% 3405
2021
Q1
$4.01M Sell
469,853
-107,211
-19% -$916K ﹤0.01% 3639
2020
Q4
$3.35M Buy
577,064
+441,956
+327% +$2.57M ﹤0.01% 3511
2020
Q3
$358K Sell
135,108
-24,000
-15% -$63.6K ﹤0.01% 3866
2020
Q2
$466K Hold
159,108
﹤0.01% 3784
2020
Q1
$275K Sell
159,108
-690
-0.4% -$1.19K ﹤0.01% 3808
2019
Q4
$687K Sell
159,798
-7,843,266
-98% -$33.7M ﹤0.01% 3729
2019
Q3
$968K Buy
8,003,064
+7,526,695
+1,580% +$910K ﹤0.01% 3662
2019
Q2
$54K Sell
476,369
-260,907
-35% -$29.6K ﹤0.01% 4102
2019
Q1
$752K Buy
737,276
+111,371
+18% +$114K ﹤0.01% 3695
2018
Q4
$770K Buy
625,905
+258,747
+70% +$318K ﹤0.01% 3637
2018
Q3
$448K Buy
367,158
+177,321
+93% +$216K ﹤0.01% 3871
2018
Q2
$649K Buy
189,837
+103,430
+120% +$354K ﹤0.01% 3784
2018
Q1
$298K Sell
86,407
-833,219
-91% -$2.87M ﹤0.01% 3892
2017
Q4
$241K Sell
919,626
-240,876
-21% -$63.1K ﹤0.01% 3896
2017
Q3
$410K Sell
1,160,502
-171,932
-13% -$60.7K ﹤0.01% 3788
2017
Q2
$774K Buy
1,332,434
+13,302
+1% +$7.73K ﹤0.01% 3633
2017
Q1
$804K Buy
1,319,132
+1,119,811
+562% +$683K ﹤0.01% 3638
2016
Q4
$386K Buy
+199,321
New +$386K ﹤0.01% 3782